Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Issue 10 (28th July 2014)
- Record Type:
- Journal Article
- Title:
- Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Issue 10 (28th July 2014)
- Main Title:
- Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
- Authors:
- Kelemen, Linda E.
Terry, Kathryn L.
Goodman, Marc T.
Webb, Penelope M.
Bandera, Elisa V.
McGuire, Valerie
Rossing, Mary Anne
Wang, Qinggang
Dicks, Ed
Tyrer, Jonathan P.
Song, Honglin
Kupryjanczyk, Jolanta
Dansonka‐Mieszkowska, Agnieszka
Plisiecka‐Halasa, Joanna
Timorek, Agnieszka
Menon, Usha
Gentry‐Maharaj, Aleksandra
Gayther, Simon A.
Ramus, Susan J.
Narod, Steven A.
Risch, Harvey A.
McLaughlin, John R.
Siddiqui, Nadeem
Glasspool, Rosalind
Paul, James
Carty, Karen
Gronwald, Jacek
Lubiński, Jan
Jakubowska, Anna
Cybulski, Cezary
Kiemeney, Lambertus A.
Massuger, Leon F. A. G.
van Altena, Anne M.
Aben, Katja K. H.
Olson, Sara H.
Orlow, Irene
Cramer, Daniel W.
Levine, Douglas A.
Bisogna, Maria
Giles, Graham G.
Southey, Melissa C.
Bruinsma, Fiona
Kjær, Susanne K.
Høgdall, Estrid
Jensen, Allan
Høgdall, Claus K.
Lundvall, Lene
Engelholm, Svend‐Aage
Heitz, Florian
du Bois, Andreas
Harter, Philipp
Schwaab, Ira
Butzow, Ralf
Nevanlinna, Heli
Pelttari, Liisa M.
Leminen, Arto
Thompson, Pamela J.
Lurie, Galina
Wilkens, Lynne R.
Lambrechts, Diether
Van Nieuwenhuysen, Els
Lambrechts, Sandrina
Vergote, Ignace
Beesley, Jonathan
AOCS Study Group/ACS Investigators
Fasching, Peter A.
Beckmann, Matthias W.
Hein, Alexander
Ekici, Arif B.
Doherty, Jennifer A.
Wu, Anna H.
Pearce, Celeste L.
Pike, Malcolm C.
Stram, Daniel
Chang‐Claude, Jenny
Rudolph, Anja
Dörk, Thilo
Dürst, Matthias
Hillemanns, Peter
Runnebaum, Ingo B.
Bogdanova, Natalia
Antonenkova, Natalia
Odunsi, Kunle
Edwards, Robert P.
Kelley, Joseph L.
Modugno, Francesmary
Ness, Roberta B.
Karlan, Beth Y.
Walsh, Christine
Lester, Jenny
Orsulic, Sandra
Fridley, Brooke L.
Vierkant, Robert A.
Cunningham, Julie M.
Wu, Xifeng
Lu, Karen
Liang, Dong
Hildebrandt, Michelle A.T.
Weber, Rachel Palmieri
Iversen, Edwin S.
Tworoger, Shelley S.
Poole, Elizabeth M.
Salvesen, Helga B.
Krakstad, Camilla
Bjorge, Line
Tangen, Ingvild L.
Pejovic, Tanja
Bean, Yukie
Kellar, Melissa
Wentzensen, Nicolas
Brinton, Louise A.
Lissowska, Jolanta
Garcia‐Closas, Montserrat
Campbell, Ian G.
Eccles, Diana
Whittemore, Alice S.
Sieh, Weiva
Rothstein, Joseph H.
Anton‐Culver, Hoda
Ziogas, Argyrios
Phelan, Catherine M.
Moysich, Kirsten B.
Goode, Ellen L.
Schildkraut, Joellen M.
Berchuck, Andrew
Pharoah, Paul D.P.
Sellers, Thomas A.
Brooks‐Wilson, Angela
Cook, Linda S.
Le, Nhu D.
… (more) - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="mnfr2230-sec-0010" sec-type="section"> <title>Scope</title> <p>We reevaluated previously reported associations between variants in pathways of one‐carbon (1‐C) (folate) transfer genes and ovarian carcinoma (OC) risk, and in related pathways of purine and pyrimidine metabolism, and assessed interactions with folate intake.</p> </sec> <sec id="mnfr2230-sec-0020" sec-type="section"> <title>Methods and results</title> <p>Odds ratios (OR) for 446 genetic variants were estimated among 13 410 OC cases and 22 635 controls, and among 2281 cases and 3444 controls with folate information. Following multiple testing correction, the most significant main effect associations were for dihydropyrimidine dehydrogenase (<italic>DPYD</italic>) variants rs11587873 (OR = 0.92; <italic>p</italic> = 6 × 10<sup>−5</sup>) and rs828054 (OR = 1.06; <italic>p</italic> = 1 × 10<sup>−4</sup>). Thirteen variants in the pyrimidine metabolism genes, <italic>DPYD</italic>, <italic>DPYS</italic>, <italic>PPAT</italic>, and <italic>TYMS</italic>, also interacted significantly with folate in a multivariant analysis (corrected <italic>p</italic> = 9.9 × 10<sup>−6</sup>) but collectively explained only 0.2% of OC risk. Although no other associations were significant after multiple testing correction, variants in <italic>SHMT1</italic> in 1‐C transfer, previously reported with OC, suggested lower risk at higher folate<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="mnfr2230-sec-0010" sec-type="section"> <title>Scope</title> <p>We reevaluated previously reported associations between variants in pathways of one‐carbon (1‐C) (folate) transfer genes and ovarian carcinoma (OC) risk, and in related pathways of purine and pyrimidine metabolism, and assessed interactions with folate intake.</p> </sec> <sec id="mnfr2230-sec-0020" sec-type="section"> <title>Methods and results</title> <p>Odds ratios (OR) for 446 genetic variants were estimated among 13 410 OC cases and 22 635 controls, and among 2281 cases and 3444 controls with folate information. Following multiple testing correction, the most significant main effect associations were for dihydropyrimidine dehydrogenase (<italic>DPYD</italic>) variants rs11587873 (OR = 0.92; <italic>p</italic> = 6 × 10<sup>−5</sup>) and rs828054 (OR = 1.06; <italic>p</italic> = 1 × 10<sup>−4</sup>). Thirteen variants in the pyrimidine metabolism genes, <italic>DPYD</italic>, <italic>DPYS</italic>, <italic>PPAT</italic>, and <italic>TYMS</italic>, also interacted significantly with folate in a multivariant analysis (corrected <italic>p</italic> = 9.9 × 10<sup>−6</sup>) but collectively explained only 0.2% of OC risk. Although no other associations were significant after multiple testing correction, variants in <italic>SHMT1</italic> in 1‐C transfer, previously reported with OC, suggested lower risk at higher folate (<italic>p</italic><sub>interaction</sub> = 0.03–0.006).</p> </sec> <sec id="mnfr2230-sec-0030" sec-type="section"> <title>Conclusion</title> <p>Variation in pyrimidine metabolism genes, particularly <italic>DPYD</italic>, which was previously reported to be associated with OC, may influence risk; however, stratification by folate intake is unlikely to modify disease risk appreciably in these women. <italic>SHMT1</italic> SNP‐by‐folate interactions are plausible but require further validation. Polymorphisms in selected genes in purine metabolism were not associated with OC.</p> </sec> </abstract> … (more)
- Is Part Of:
- Molecular nutrition & food research. Volume 58:Issue 10(2014:Oct.)
- Journal:
- Molecular nutrition & food research
- Issue:
- Volume 58:Issue 10(2014:Oct.)
- Issue Display:
- Volume 58, Issue 10 (2014)
- Year:
- 2014
- Volume:
- 58
- Issue:
- 10
- Issue Sort Value:
- 2014-0058-0010-0000
- Page Start:
- 2023
- Page End:
- 2035
- Publication Date:
- 2014-07-28
- Subjects:
- Food -- Biotechnology -- Periodicals
Food -- Microbiology -- Periodicals
Nutrition -- Periodicals
Food -- Toxicology -- Periodicals
Nutrition -- Periodicals
Food Microbiology -- Periodicals
Food Technology -- Periodicals
Molecular Biology -- Periodicals
664.0705 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/mnfr.201400068 ↗
- Languages:
- English
- ISSNs:
- 1613-4125
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817992
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3461.xml